Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,577,393
-
Total 13F shares
-
28,092,578
-
Share change
-
+11,431,752
-
Total reported value
-
$121,918,732
-
Put/Call ratio
-
23%
-
Price per share
-
$4.34
-
Number of holders
-
117
-
Value change
-
+$50,159,924
-
Number of buys
-
66
-
Number of sells
-
19
Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q4 2024
As of 31 Dec 2024 Cardiff Oncology, Inc. - Common Stock (CRDF) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,092,578 shares of stock of the company.
Largest 10 holders included COMMODORE CAPITAL LP, BlackRock, Inc., Pfizer Inc, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, ACORN CAPITAL ADVISORS, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, MAI Capital Management, and STATE STREET CORP.
This table shows 117 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.